RxSight Shares Outstanding History (RXST)
RxSight reported 41.2M shares outstanding at the end of fiscal 2025.
View full RxSight company overviewRxSight annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 41.2M | 813,785 | +2.01% |
| 2024 | 2024-12-31 | 40.4M | 4.3M | +11.87% |
| 2023 | 2023-12-31 | 36.1M | 7.9M | +27.84% |
| 2022 | 2022-12-31 | 28.3M | 901,643 | +3.29% |
| 2021 | 2021-12-31 | 27.4M | — | — |
RxSight quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 41.6M | 672,001 | +1.64% |
| Q1 2026 | 2026-03-31 | 41.4M | 795,580 | +1.96% |
| Q4 2025 | 2025-12-31 | 41.2M | 813,785 | +2.01% |
| Q3 2025 | 2025-09-30 | 41.1M | 827,445 | +2.06% |
| Q2 2025 | 2025-06-30 | 40.9M | 1.3M | +3.27% |
| Q1 2025 | 2025-03-31 | 40.6M | 3.4M | +9.22% |
| Q4 2024 | 2024-12-31 | 40.4M | 4.3M | +11.87% |
| Q3 2024 | 2024-09-30 | 40.3M | 4.4M | +12.29% |
| Q2 2024 | 2024-06-30 | 39.6M | 4.4M | +12.65% |
| Q1 2024 | 2024-03-31 | 37.2M | 3.2M | +9.41% |
| Q4 2023 | 2023-12-31 | 36.1M | 7.9M | +27.84% |
| Q3 2023 | 2023-09-30 | 35.8M | 8.1M | +29.32% |
| Q2 2023 | 2023-06-30 | 35.2M | 7.5M | +27.28% |
| Q1 2023 | 2023-03-31 | 34.0M | 6.5M | +23.58% |
| Q4 2022 | 2022-12-31 | 28.3M | 901,643 | +3.29% |
| Q3 2022 | 2022-09-30 | 27.7M | 395,078 | +1.45% |
| Q2 2022 | 2022-06-30 | 27.6M | 23.5M | +569.98% |
| Q1 2022 | 2022-03-31 | 27.5M | — | — |
| Q4 2021 | 2021-12-31 | 27.4M | — | — |
| Q3 2021 | 2021-09-30 | 27.3M | — | — |
| Q2 2021 | 2021-06-30 | 4.1M | — | — |
RxSight shares outstanding trends
Across the available reported history, RxSight's shares outstanding moved from 40.4M to 41.2M, a change of 813,785. The latest reported quarter, Q2 2026, shows 41.6M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RxSight filings at SEC.gov ↗